Kaplan–Meier analysis indicated that patients with CCUS and lower-risk MDS with a LEP promoter methylation above the cutoff (39.57%) had inferior OS (p = 0.042, Additional file 2: Fig. S5). The gene discussed is LEP; the disease is myelodysplastic syndrome.